{
  "cik": 1401040,
  "cik_padded": "0001401040",
  "entityName": "DiaMedica Therapeutics Inc.",
  "fiscal_years": [
    {
      "accn": "0001437749-26-010342",
      "filed": "2026-03-30",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 40000.0,
        "cash": 15647000.0,
        "free_cash_flow": -29102000.0,
        "net_income": -32766000.0,
        "operating_cash_flow": -29062000.0,
        "operating_income": -34397000.0,
        "stockholders_equity": 56111000.0,
        "total_assets": 61371000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.608377585502618,
        "roa_period_end": -0.5339003763992766,
        "roe_avg2y": -0.676780716520877,
        "roe_period_end": -0.5839496711874677
      }
    },
    {
      "accn": "0001437749-26-010342",
      "filed": "2026-03-30",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 25000.0,
        "cash": 3025000.0,
        "free_cash_flow": -22101000.0,
        "net_income": -24444000.0,
        "operating_cash_flow": -22076000.0,
        "operating_income": -26681000.0,
        "stockholders_equity": 40718000.0,
        "total_assets": 46345000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.48642356101686485,
        "roa_period_end": -0.5274355378142195,
        "roe_avg2y": -0.5326940888041406,
        "roe_period_end": -0.6003241809519132
      }
    },
    {
      "accn": "0001437749-26-010342",
      "filed": "2026-03-30",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 24000.0,
        "cash": 4543000.0,
        "free_cash_flow": -18752000.0,
        "net_income": -19381000.0,
        "operating_cash_flow": -18728000.0,
        "operating_income": -21267000.0,
        "stockholders_equity": 51057000.0,
        "total_assets": 54160000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.43771667325391,
        "roa_period_end": -0.3578471196454948,
        "roe_avg2y": -0.46766565320206555,
        "roe_period_end": -0.37959535421195917
      }
    },
    {
      "accn": "0001437749-25-008018",
      "filed": "2025-03-17",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 81000.0,
        "cash": 4728000.0,
        "free_cash_flow": -11592000.0,
        "net_income": -13676000.0,
        "operating_cash_flow": -11511000.0,
        "operating_income": -14001000.0,
        "stockholders_equity": 31827000.0,
        "total_assets": 34395000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.3421309383834088,
        "roa_period_end": -0.3976159325483355,
        "roe_avg2y": -0.3606017059761902,
        "roe_period_end": -0.42969805511044085
      }
    },
    {
      "accn": "0001437749-24-008522",
      "filed": "2024-03-19",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 22000.0,
        "cash": 4707000.0,
        "free_cash_flow": -12274000.0,
        "net_income": -13592000.0,
        "operating_cash_flow": -12252000.0,
        "operating_income": -13646000.0,
        "stockholders_equity": 44024000.0,
        "total_assets": 45551000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.36911712788203027,
        "roa_period_end": -0.2983908146912252,
        "roe_avg2y": -0.38813215682914987,
        "roe_period_end": -0.3087406868980556
      }
    },
    {
      "accn": "0001437749-23-008189",
      "filed": "2023-03-28",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 47000.0,
        "cash": 7409000.0,
        "free_cash_flow": -9232000.0,
        "net_income": -12292000.0,
        "operating_cash_flow": -9185000.0,
        "operating_income": -12699000.0,
        "stockholders_equity": 26014000.0,
        "total_assets": 28095000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.661785291267363,
        "roa_period_end": -0.4375155721658658,
        "roe_avg2y": -0.730992239303024,
        "roe_period_end": -0.47251479972322596
      }
    },
    {
      "accn": "0001437749-22-006163",
      "filed": "2022-03-14",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 2000.0,
        "cash": 3883000.0,
        "free_cash_flow": -9104000.0,
        "net_income": -10649000.0,
        "operating_cash_flow": -9102000.0,
        "operating_income": -11593000.0,
        "stockholders_equity": 7617000.0,
        "total_assets": 9053000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.7775262850467289,
        "roa_period_end": -1.1762951507787474,
        "roe_avg2y": -0.8642967291615941,
        "roe_period_end": -1.3980569778127871
      }
    },
    {
      "accn": "0001437749-21-005541",
      "filed": "2021-03-10",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 50000.0,
        "cash": 16823000.0,
        "free_cash_flow": -5746000.0,
        "net_income": -5734000.0,
        "operating_cash_flow": -5696000.0,
        "operating_income": -6761000.0,
        "stockholders_equity": 17025000.0,
        "total_assets": 18339000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.5693858298992106,
        "roa_period_end": -0.3126669938382682,
        "roe_avg2y": -0.6434021543985637,
        "roe_period_end": -0.336798825256975
      }
    },
    {
      "accn": "0001437749-20-005906",
      "filed": "2020-03-23",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD"
      },
      "fundamentals": {
        "capex": 22000.0,
        "cash": 1353000.0,
        "free_cash_flow": -3922000.0,
        "net_income": -4260000.0,
        "operating_cash_flow": -3900000.0,
        "operating_income": -4519000.0,
        "stockholders_equity": 799000.0,
        "total_assets": 1802000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": -4.460732984293194
      }
    },
    {
      "accn": "0001437749-19-005272",
      "filed": "2019-03-19",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": 1111000.0
      },
      "period_end": "2016-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001437749-26-010342",
    "filed": "2026-03-30",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001401040.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001401040.json"
  },
  "ticker": "DMAC"
}